These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 7131714

  • 1. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease.
    Kijima Y, Kamiya T, Suzuki A, Hirose O, Manabe H.
    Jpn Circ J; 1982 Nov; 46(11):1239-42. PubMed ID: 7131714
    [Abstract] [Full Text] [Related]

  • 2. [Two-dimensional echocardiography of coronary artery in Kawasaki disease (MCLS): detection, changes in acute phase, and follow-up observation of the aneurysm (author's transl)].
    Hirose O, Misawa H, Kijima Y, Yamada O, Arakaki Y, Kajino Y, Ryujin Y, Kowata T, Echigo S, Kamiya T.
    J Cardiogr; 1981 Mar; 11(1):89-104. PubMed ID: 7264399
    [Abstract] [Full Text] [Related]

  • 3. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC, Aronoff SC.
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
    Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, Romano A, Bierman FZ.
    Arch Pediatr Adolesc Med; 2006 Jul; 160(7):686-90. PubMed ID: 16818833
    [Abstract] [Full Text] [Related]

  • 5. Kawasaki disease: effect of treatment on coronary artery involvement.
    Kato H, Koike S, Yokoyama T.
    Pediatrics; 1979 Feb; 63(2):175-9. PubMed ID: 440805
    [Abstract] [Full Text] [Related]

  • 6. [Two-dimensional echocardiographic study of coronary artery lesion in Kawasaki disease: a new approach to visualize the right coronary artery].
    Ichinose E, Eto Y, Takechi T, Yoshioka F, Kato H.
    J Cardiogr; 1982 Mar; 12(1):111-24. PubMed ID: 7119487
    [Abstract] [Full Text] [Related]

  • 7. [Kawasaki disease with coronary involvement].
    Zarazaga G, Salazar J, Oliván MJ, García MD, Felipe J.
    An Esp Pediatr; 1983 Jan; 18(1):62-7. PubMed ID: 6870079
    [No Abstract] [Full Text] [Related]

  • 8. [Therapy of Kawasaki disease in the acute phase: steroid and aspirin therapy].
    Kato H, Ichinose E.
    Nihon Rinsho; 1983 Sep; 41(9):2092-6. PubMed ID: 6663745
    [No Abstract] [Full Text] [Related]

  • 9. Cross-sectional echocardiographic diagnosis of coronary artery aneurysms in patients with the mucocutaneous lymph node syndrome.
    Yoshikawa J, Yanagihara K, Owaki T, Kato H, Takagi Y, Okumachi F, Fukaya T, Tomita Y, Baba K.
    Circulation; 1979 Jan; 59(1):133-9. PubMed ID: 758104
    [Abstract] [Full Text] [Related]

  • 10. Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease.
    Koren G, Rose V, Lavi S, Rowe R.
    JAMA; 1985 Aug 09; 254(6):767-9. PubMed ID: 4009911
    [Abstract] [Full Text] [Related]

  • 11. Subcostal two-dimensional echocardiographic imaging of peripheral right coronary artery in Kawasaki disease.
    Yoshida H, Maeda T, Funabashi T, Nakaya S, Takabatake S, Taniguchi N.
    Circulation; 1982 May 09; 65(5):956-61. PubMed ID: 7074760
    [Abstract] [Full Text] [Related]

  • 12. [The mucocutaneous lymph node syndrome (Kawasaki syndrome). A case with gallbladder hydrops and coronary artery aneurysm].
    Fritz ME, Giambonini S, Jenni R, D'Apuzzo V.
    Schweiz Med Wochenschr; 1981 Apr 18; 111(16):566-71. PubMed ID: 7233135
    [Abstract] [Full Text] [Related]

  • 13. Effect of dipyridamole on the blood flow in coronary aneurysms resulting from Kawasaki disease.
    Kobayashi T, Sone K.
    Pediatr Cardiol; 1994 Apr 18; 15(6):263-7. PubMed ID: 7838798
    [Abstract] [Full Text] [Related]

  • 14. The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness.
    Yang TJ, Lin MT, Lu CY, Chen JM, Lee PI, Huang LM, Wu MH, Chang LY.
    J Microbiol Immunol Infect; 2018 Jun 18; 51(3):321-331. PubMed ID: 28927685
    [Abstract] [Full Text] [Related]

  • 15. High regression rate of coronary aneurysms developed in patients with immune globulin-resistant Kawasaki disease treated with steroid pulse therapy.
    Adachi S, Sakaguchi H, Kuwahara T, Uchida Y, Fukao T, Kondo N.
    Tohoku J Exp Med; 2010 Apr 18; 220(4):285-90. PubMed ID: 20410679
    [Abstract] [Full Text] [Related]

  • 16. Detection of coronary arterial lesions by two dimensional echocardiography in patients with Kawasaki disease.
    Ishihara H, Watanabe S, Izumida N, Tuchiya S, Hosaki J.
    Bull Tokyo Med Dent Univ; 1984 Sep 18; 31(3):139-43. PubMed ID: 6598414
    [Abstract] [Full Text] [Related]

  • 17. Coronary artery aneurysms due to Kawasaki disease: diagnosis with ultrafast CT.
    Frey EE, Matherne GP, Mahoney LT, Sato Y, Stanford W, Smith WL.
    Radiology; 1988 Jun 18; 167(3):725-6. PubMed ID: 3363129
    [Abstract] [Full Text] [Related]

  • 18. Noninvasive visualization of coronary arterial aneurysm in infants and young children with mucocutaneous lymph node syndrome with two dimensional echocardiography.
    Hiraishi S, Yashiro K, Kusano S.
    Am J Cardiol; 1979 Jun 18; 43(6):1225-33. PubMed ID: 443180
    [Abstract] [Full Text] [Related]

  • 19. Subcostal 2-dimensional echocardiographic imaging of peripheral left coronary artery aneurysms in Kawasaki disease.
    Maeda T, Yoshida H, Funabashi T, Nakaya S, Takabatake S, Ohno T, Taniguchi N.
    Am J Cardiol; 1983 Jul 18; 52(1):48-52. PubMed ID: 6858926
    [Abstract] [Full Text] [Related]

  • 20. [Kawasaki disease].
    Blom US, Zeller B, Perminow KV, Fjaerli HO.
    Tidsskr Nor Laegeforen; 2000 Nov 30; 120(29):3540-3. PubMed ID: 11188381
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.